SpringWorks Therapeutics, Inc. financial data

Symbol
SWTX on Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
Location
100 Washington Boulevard, Stamford, Connecticut
State of incorporation
Delaware
Fiscal year end
December 31
Latest financial report
Q1 2024 - May 2, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 789 % -36%
Debt-to-equity 16.1 % +32.1%
Return On Assets -57.3 % -11.3%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 74.1 M shares +18.5%
Common Stock, Shares, Outstanding 74.1 M shares +18.5%
Entity Public Float 1.6 B USD +76.6%
Common Stock, Value, Issued 7 K USD +16.7%
Weighted Average Number of Shares Outstanding, Basic 73.8 M shares +18.4%
Weighted Average Number of Shares Outstanding, Diluted 73.8 M shares +18.4%

Income Statement

Label TTM Value / Value Unit Change %
Research and Development Expense 171 M USD +17.2%
General and Administrative Expense 178 M USD +47.9%
Costs and Expenses 115 M USD +47.9%
Operating Income (Loss) -359 M USD -21%
Nonoperating Income (Expense) 25 M USD +113%
Net Income (Loss) Attributable to Parent -339 M USD -17.3%
Earnings Per Share, Basic -5.15 USD/shares 0%
Earnings Per Share, Diluted -5.15 USD/shares 0%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 118 M USD +15.3%
Marketable Securities, Current 525 M USD +94.7%
Cash, Cash Equivalents, and Short-term Investments 573 M USD +8.5%
Accounts Receivable, after Allowance for Credit Loss, Current 15.5 M USD
Inventory, Net 5.22 M USD
Assets, Current 472 M USD -12.2%
Property, Plant and Equipment, Net 18.3 M USD +16.1%
Operating Lease, Right-of-Use Asset 5.82 M USD -11.9%
Other Assets, Noncurrent 14.8 M USD +411%
Assets 657 M USD +15.4%
Accounts Payable, Current 7.01 M USD +0.3%
Employee-related Liabilities, Current 17.1 M USD +87.5%
Accrued Liabilities, Current 56.3 M USD +96.2%
Contract with Customer, Liability, Current 4.65 M USD +175%
Liabilities, Current 68.9 M USD +82.5%
Contract with Customer, Liability, Noncurrent 14.9 M USD -16.6%
Operating Lease, Liability, Noncurrent 5.58 M USD -16.3%
Other Liabilities, Noncurrent 14.7 M USD +11091%
Liabilities 89.4 M USD +43.5%
Accumulated Other Comprehensive Income (Loss), Net of Tax -113 K USD +30.2%
Retained Earnings (Accumulated Deficit) -982 M USD -52.7%
Stockholders' Equity Attributable to Parent 567 M USD +11.9%
Liabilities and Equity 657 M USD +15.4%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -78.9 M USD -27.7%
Net Cash Provided by (Used in) Financing Activities -552 K USD +70.1%
Net Cash Provided by (Used in) Investing Activities 21.5 M USD -78.2%
Common Stock, Shares Authorized 150 M shares 0%
Common Stock, Shares, Issued 74.4 M shares +18.7%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -58 M USD -266%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 119 M USD +15.2%
Deferred Tax Assets, Valuation Allowance 227 M USD +44%
Deferred Tax Assets, Gross 230 M USD +44.6%
Operating Lease, Liability 7.06 M USD +34.4%
Depreciation 253 K USD +134%
Payments to Acquire Property, Plant, and Equipment 577 K USD -80.6%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -339 M USD -17.8%
Lessee, Operating Lease, Liability, to be Paid 8.03 M USD +33.7%
Property, Plant and Equipment, Gross 20.6 M USD +39%
Operating Lease, Liability, Current 981 K USD +154%
Lessee, Operating Lease, Liability, to be Paid, Year Two 2 M USD +73.1%
Lessee, Operating Lease, Liability, to be Paid, Year One 1.48 M USD +88.5%
Operating Lease, Weighted Average Discount Rate, Percent 0.06 pure +47.6%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 970 K USD +29%
Lessee, Operating Lease, Liability, to be Paid, Year Three 2 M USD +69.1%
Deferred Tax Assets, Operating Loss Carryforwards 121 M USD +30.1%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 10 M shares 0%
Lessee, Operating Lease, Liability, to be Paid, Year Four 1.9 M USD +57%
Additional Paid in Capital 1.56 B USD +35.3%
Preferred Stock, Shares Outstanding 0 shares
Depreciation, Depletion and Amortization 729 K USD +188%
Share-based Payment Arrangement, Expense 102 M USD +28.2%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%